Found: 14
Select item for more details and to access through your institution.
Nutritional counseling improves mortality and prevents hepatic encephalopathy in patients with alcohol‐associated liver disease.
- Published in:
- Hepatology Research, 2024, v. 54, n. 11, p. 1089, doi. 10.1111/hepr.14053
- By:
- Publication type:
- Article
Unresectable Combined Hepatocellular-cholangiocarcinoma Treated with Combination Therapy Consisting of Durvalumab Plus Tremelimumab.
- Published in:
- Internal Medicine, 2024, v. 63, n. 19, p. 2631, doi. 10.2169/internalmedicine.3071-23
- By:
- Publication type:
- Article
A case of A20 haploinsufficiency complicated by autoimmune hepatitis.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 606, doi. 10.1111/hepr.14003
- By:
- Publication type:
- Article
Usefulness of the Global Leadership Initiative on Malnutrition criteria to predict sarcopenia and mortality in patients with chronic liver disease.
- Published in:
- Hepatology Research, 2022, v. 52, n. 11, p. 928, doi. 10.1111/hepr.13816
- By:
- Publication type:
- Article
Adverse Events in Targeted Therapy for Unresectable Hepatocellular Carcinoma Predict Clinical Outcomes.
- Published in:
- Cancers, 2024, v. 16, n. 18, p. 3150, doi. 10.3390/cancers16183150
- By:
- Publication type:
- Article
Lenvatinib Exacerbates the Decrease in Skeletal Muscle Mass in Patients with Hepatocellular Carcinoma, Whereas Atezolizumab Plus Bevacizumab Does Not.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 442, doi. 10.3390/cancers16020442
- By:
- Publication type:
- Article
Lenvatinib or Sorafenib Treatment Causing a Decrease in Skeletal Muscle Mass, an Independent Prognostic Factor in Hepatocellular Carcinoma: A Survival Analysis Using Time-Varying Covariates.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4223, doi. 10.3390/cancers15174223
- By:
- Publication type:
- Article
Changes in ALBI Score and PIVKA-II within Three Months after Commencing Atezolizumab Plus Bevacizumab Treatment Affect Overall Survival in Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6089, doi. 10.3390/cancers14246089
- By:
- Publication type:
- Article
Sustained Virological Response Is the Most Effective in Preventing Hepatocellular Carcinoma Recurrence after Curative Treatment in Hepatitis C Virus-Positive Patients: A Study Using Decision Tree Analysis.
- Published in:
- International Journal of Translational Medicine, 2022, v. 2, n. 3, p. 345, doi. 10.3390/ijtm2030027
- By:
- Publication type:
- Article
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 10, p. 932, doi. 10.1007/s00535-024-02137-4
- By:
- Publication type:
- Article
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 9, p. 849, doi. 10.1007/s00535-024-02126-7
- By:
- Publication type:
- Article
A survey questionnaire evaluating physical activity patterns and determinants in patients with chronic liver disease.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 1, p. 45, doi. 10.1007/s00535-023-02047-x
- By:
- Publication type:
- Article
FIB‑4 index and NAFLD fibrosis score are useful indicators for screening high‑risk groups of non‑viral hepatocellular carcinoma.
- Published in:
- Molecular & Clinical Oncology, 2023, v. 19, n. 4, p. N.PAG, doi. 10.3892/mco.2023.2676
- By:
- Publication type:
- Article
Animal naming test stratifies the risk of falls and fall-related fractures in patients with cirrhosis.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-54951-8
- By:
- Publication type:
- Article